Privately held transdermal drug delivery firm Zosano Pharma said it has appointed Kleanthis Xanthopoulos to its board of directors.
Xanthopolis is currently president and CEO of microRNA drug developer Regulus Therapeutics. Prior to that, he was a co-founder and president/CEO of Anadys Pharmaceuticals.